NBT Analytics celebrates funding success

The Amsterdam based startup NBT Analytics B.V., a spin-off from the Vrije Universiteit Amsterdam, has shown funding success. NBT Analytics specialises in state-of-the-art EEG analysis for clinical trials and provides detailed insights on the influence of drugs on the brain by offering a comprehensive selection of biomarkers and identifying drug-specific indices. NBT Analytics has succeeded in obtaining a € 100,000 preseed loan from IXA, as well as a grant of € 40,000 from the technology foundation STW. Now concentrating on expanding their biomarker portfolio and building the team, NBT Analytics is determined to improve drug development through innovative EEG analysis.